There has been a growing interest in cannabidiol (CBD), a non-psychoactive cannabinoid with essential health potentials, from quelling seizures to easing chronic pain. Yet along with the positive development, there are also surging proliferation of misconceptions regarding it. The most common are as follows:
THC is recreational. CBD is medical
The truth is, tetrahydrocannabinol (THC), the cannabinoid which gets you high also comes with valuable health benefits. Researchers at San Diego’s Scripps Research Center found that this compound prevents the production of an enzyme responsible to the buildup of beta-amyloid plaque, the major contributory factor of dementia among patients of Alzheimer’s disease.
In fact, single molecule THC known as Marinol is recognized by the federal government for its appetite boosting and anti-nausea potentials. This made it classified under a Schedule III drug which groups medicinal substances with minimal abuse properties. What is classified as a dangerous Schedule I drug is the entire marijuana plant with no medical value.
CBD is good while THC is bad
The strategic retreat of drug warriors continues to demonize THC while giving ground on CBD. Prohibitionists of marijuana exploit the positive development surrounding CBD to all the more stigmatize the cannabis rich in THC, tagging the latter as the bad guy while CBD is groomed as the good one. This is mainly because THC gets you high while CBD does not. The truth is, each takes a role in boosting the therapeutic benefits of cannabis.
CBD works best without THC.
CBD and THC work best when combined. Series of research have proven that two powerful cannabinoids have a synergistic working relationship in boosting the health benefits of each other. A British study involving an animal model of colitis have found that CBD enhances the anti-inflammatory potential of THC.
Researchers at San Francisco’s California Pacific Medical Center likewise discovered that combining THC and CBD makes a more powerful ant-tumor treatment when compared with either isolated compound when tested on breast cancer and brain cancer cell lines.
A comprehensive clinical study also found that the combination of the two compounds benefits neuropathic pain management the most when compared with either compound as an isolated molecule.
CBD is legal elsewhere in the U.S.
Imported CBD hemp oil distributors claim that it is legal to sell their products elsewhere in the U.S. provided they contain no more than 0.3%. The truth is, it’s quite complicated.
Growing hemp for commercial purposes is prohibited by the federal government, yet selling of imported industrial hemp products with minimal THC content is allowed provided they are not made from flowers and leaves, but from the plant’s stalk or seed. The catch is: CBD cannot be extracted or pressed from hemp seed. The compound can be obtained from the leaves, flower, and, from the stalk but on minimal extent. The credibility of hemp oil startups will be in question the moment they mention their product was sourced from stalk and hempseed.
It does not matter where CBD is sourced from
The truth is, it matters. Notwithstanding legal issues, leaves and flower-tops are a potential source of CBD, yet the optimal source is the hemp. Industrial hemp usually has lower CBD content than those derived from cannabis with rich CBD. Because a large volume of industrial hemp is needed to produce a small amount of cannabidiol, the risk of toxic contaminants considering that hemp draws heavy metals from the soil is high.
A synthetic CBD – one sourced from industrial hemp and refined in the laboratory is lacking secondary cannabinoids and essential therapeutic terpenes which interact with THC and CBD to boost their medicinal values.